These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 19620045)

  • 1. [Matrine enhances the cytotoxic sensitivity of ABCG2high nasopharyngeal carcinoma cells to natural killer cells by inducing high expression of NKG2D receptor ligands].
    Huang YX; Wang Y; Sun M; Zhou XY; Deng L; Guo KY
    Nan Fang Yi Ke Da Xue Xue Bao; 2009 Jul; 29(7):1329-32. PubMed ID: 19620045
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Different cytotoxicity of NK cells against high and low expression of ATP-binding cassette transporter (ABCG(2)) of human multi-drug resistant nasopharyngeal carcinoma cells].
    Huang YX; Wang Y; Li YJ; Song CY; Guo KY
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2009 Feb; 25(2):128-32. PubMed ID: 19174009
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of sorafenib and sunitinib in the induction of expressions of NKG2D ligands in nasopharyngeal carcinoma with high expression of ABCG2.
    Huang Y; Wang Y; Li Y; Guo K; He Y
    J Cancer Res Clin Oncol; 2011 May; 137(5):829-37. PubMed ID: 20809412
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Expression of NKG2D ligands in multidrug-resistant nasopharyngeal carcinoma cell line CNE2/DDP and their effects on cytotoxicity of natural killer cells].
    Mei JZ; Guo KY; Wei HM; Song CY
    Nan Fang Yi Ke Da Xue Xue Bao; 2007 Jun; 27(6):887-9. PubMed ID: 17584663
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Effects of matrine on the expression of NKG2D ligands in leukemia cells].
    Ma LD; Lu XZ; Zhu ZC; Jiang LJ; Zhou M; Qian SX; Li JY
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2013 Dec; 21(6):1429-34. PubMed ID: 24370024
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Up-regulation of NKG2D ligand ULBP2 by matrine in K562 cells and the underlying molecular mechanisms].
    Ma L; Zhu Z; Lu X; Jiang L; Zhou M; Qian S; Li J
    Zhonghua Xue Ye Xue Za Zhi; 2014 May; 35(5):438-42. PubMed ID: 24857216
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Immunoediting of natural killer cells by human nasopharyngeal carcinoma cell line: altered expression of KIRs and NKG2D receptors leads to reduction of natural killer cell-mediated cytolysis].
    Guo KY; Mei JZ; Yao KT
    Nan Fang Yi Ke Da Xue Xue Bao; 2007 Mar; 27(3):247-9. PubMed ID: 17425963
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Expression of NKG2D ligands on dendritic cells at different development stages and its effect on cytotoxicity of NK cells].
    Tu SF; Guo KY; Hu LS; Mei JZ; Zhou J; Sun M
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2008 Apr; 24(4):341-3, 347. PubMed ID: 18394338
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical Impact of Natural Killer Group 2D Receptor Expression and That of Its Ligand in Ovarian Carcinomas: A Retrospective Study.
    Lee GH; An HJ; Kim TH; Kim G; Park KS; Park H; Lee TH; Kwon AY
    Yonsei Med J; 2021 Apr; 62(4):288-297. PubMed ID: 33779082
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cervical cancer cell lines expressing NKG2D-ligands are able to down-modulate the NKG2D receptor on NKL cells with functional implications.
    Jimenez-Perez MI; Jave-Suarez LF; Ortiz-Lazareno PC; Bravo-Cuellar A; Gonzalez-Ramella O; Aguilar-Lemarroy A; Hernandez-Flores G; Pereira-Suarez AL; Daneri-Navarro A; del Toro-Arreola S
    BMC Immunol; 2012 Feb; 13():7. PubMed ID: 22316211
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The narrow-spectrum HDAC inhibitor entinostat enhances NKG2D expression without NK cell toxicity, leading to enhanced recognition of cancer cells.
    Zhu S; Denman CJ; Cobanoglu ZS; Kiany S; Lau CC; Gottschalk SM; Hughes DP; Kleinerman ES; Lee DA
    Pharm Res; 2015 Mar; 32(3):779-92. PubMed ID: 24203492
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hyperthermia increases natural killer cell cytotoxicity against SW-872 liposarcoma cell line.
    Farjadian S; Norouzian M; Younesi V; Ebrahimpour A; Lotfi R
    Iran J Immunol; 2013 Jun; 10(2):93-102. PubMed ID: 23811548
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Upregulated expression of NKG2D and its ligands give potential therapeutic targets for patients with thymoma.
    Xuan XY; Zhang JF; Hu GM; Li QR; Liu PP; Du Y
    Cancer Gene Ther; 2015 Jul; 22(7):368-74. PubMed ID: 26113176
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [The inhibited effect of matrine on human nasopharyngeal carcinoma CNE2 cells and the expression of apoptosis related gene Caspase in vitro].
    Xie M; He G; Shi S; Liu Y; Chen J; Tang A
    Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2014 May; 28(9):589-92. PubMed ID: 25195260
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Soluble ligands for the NKG2D receptor are released during HIV-1 infection and impair NKG2D expression and cytotoxicity of NK cells.
    Matusali G; Tchidjou HK; Pontrelli G; Bernardi S; D'Ettorre G; Vullo V; Buonomini AR; Andreoni M; Santoni A; Cerboni C; Doria M
    FASEB J; 2013 Jun; 27(6):2440-50. PubMed ID: 23395909
    [TBL] [Abstract][Full Text] [Related]  

  • 16. RAET1E2, a soluble isoform of the UL16-binding protein RAET1E produced by tumor cells, inhibits NKG2D-mediated NK cytotoxicity.
    Cao W; Xi X; Hao Z; Li W; Kong Y; Cui L; Ma C; Ba D; He W
    J Biol Chem; 2007 Jun; 282(26):18922-8. PubMed ID: 17470428
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Functional Characterisation and Analysis of the Soluble NKG2D Ligand Repertoire Detected in Umbilical Cord Blood Plasma.
    Cox ST; Danby R; Hernandez D; Laza-Briviesca R; Pearson H; Madrigal JA; Saudemont A
    Front Immunol; 2018; 9():1282. PubMed ID: 29963042
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The human NKG2D ligand ULBP2 can be expressed at the cell surface with or without a GPI anchor and both forms can activate NK cells.
    Fernández-Messina L; Ashiru O; Agüera-González S; Reyburn HT; Valés-Gómez M
    J Cell Sci; 2011 Feb; 124(Pt 3):321-7. PubMed ID: 21224393
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sunitinib Induces NK-κB-dependent NKG2D Ligand Expression in Nasopharyngeal Carcinoma and Hepatoma Cells.
    Huang YX; Chen XT; Guo KY; Li YH; Wu BY; Song CY; He YJ
    J Immunother; 2017 Jun; 40(5):164-174. PubMed ID: 28452850
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of human cytomegalovirus infection on ligands for the activating NKG2D receptor of NK cells: up-regulation of UL16-binding protein (ULBP)1 and ULBP2 is counteracted by the viral UL16 protein.
    Rölle A; Mousavi-Jazi M; Eriksson M; Odeberg J; Söderberg-Nauclér C; Cosman D; Kärre K; Cerboni C
    J Immunol; 2003 Jul; 171(2):902-8. PubMed ID: 12847260
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.